Skip to main content

Table 1 Baseline demographic and clinical participant characteristics (N = 253)

From: Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower

Variable

N = 253 (baseline)

n = 140 (completers)

N = 113 (attriters)

Age, mean (SD)

55.7 (9.2)

55.1 (9.3)

56.5 (9.0)

Female, n (%)

226 (89.3)

124 (88.6)

102 (90.3)

Race n (%)

 White

231 (91.3)

126 (90.0)

105 (92.9)

 Black/African American

12 (4.7)

6 (4.3)

6 (5.3)

 Other

10 (4.0)

8 (5.7)

2 (1.8)

Hispanic n (%)

8 (3.2)

3 (2.1)

5 (4.4)

Condition, n (%)

 Osteoarthritis (OA)

164 (64.8)

87 (62.1)

77 (68.1)

 Rheumatoid arthritis (RA)

123 (48.6)

67 (47.9)

56 (49.6)

 Fibromyalgia syndrome (FMS)

102 (40.3)

56 (40.0)

46 (40.7)

 Psoriatic arthritis (PsA)

66 (26.1)

34 (24.3)

32 (28.3)

 Osteoporosis (OP)

53 (21.0)

34 (24.3)

19 (16.8)

 Ankylosing spondylitis (AS)

40 (15.8)

18 (12.9)

22 (19.5)

 Systemic lupus erythematosus (SLE)

15 (5.9)

6 (4.3)

9 (8.0)

BMI, mean (SD)

32.2 (8.7)

31.9 (9.1)

32.6 (8.3)

Number of years living with condition, mean (SD)

11.6 (10.6)

11.4 (10.8)

11.9 (10.3)

Married, n (%)

142 (56.1)

74 (52.9)

68 (60.2)

Education, n (%)

 Post-secondary school

230 (90.9)

129 (92.1)

101 (89.4)

Employment status, n (%)

 Currently employed (full-, part-time, self-employed)

93 (36.8)

52 (37.1)

41 (36.3)

Comorbid conditions, n (%)

 Depression

128 (50.6)

74 (52.9)

54 (47.8)

 Hypertension

116 (45.8)

64 (45.7)

52 (46.0)

 Hypercholesterolemia

89 (35.2)

49 (35.0)

40 (35.4)

 Psoriasis

62 (24.5)

31 (22.1)

31 (27.4)

 Diabetes

30 (11.9)

18 (12.9)

12 (10.6)

  1. T tests were performed for continuous variables and chi square tests or Fisher’s exact tests for categorical variables to compare the difference between groups of participants who completed and attrited. No statistical significance (p < 0.05) was observed